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Abstract
Lymphomas of the gall bladder and extrahepatic bile ducts are exceedingly rare. We present the
clinicopathological features of 19 cases from our files; 14 patients had primary lymphoma (13
involving gall bladder and one involving common hepatic duct), while five had systemic lymphoma
on further work-up. Most patients presented with symptoms mimicking cholecystitis. The most
common primary lymphoma types were diffuse large B-cell lymphoma (DLBCL), extranodal
marginal zone lymphoma (EMZL), B-lymphoblastic lymphoma (B-LBL) and follicular lymphoma
(FL). Two cases had features of lymphomatous polyposis, one a case of FL and the second a case of
mantle cell lymphoma (MCL), with disease limited to the mantle zones, so-called in situ MCL. Other
rare lymphoma subtypes not previously described in this site included the extracavitary variant of
primary effusion lymphoma (PEL) and plasmablastic lymphoma (PBL). Patients with DLBCL and
EMZL were older (mean age 75.8 years) than those with other subtypes (mean age 47 years) and
more likely to have gallstones (60% vs. 12.5%). A comprehensive literature review revealed 36
primary gall bladder and 16 primary extrahepatic bile duct lymphomas. When compared to primary
gall bladder lymphomas, those involving the extrahepatic bile ducts present at a younger age (47
years vs. 63 years) usually with obstructive jaundice, and are less often associated with gallstones
(17% vs. 50%) or regional lymph node involvement (6% vs. 31%). In conclusion, primary
lymphomas of the gall bladder and extrahepatic bile ducts show a broad spectrum of disease types,
but in many respects mirror the spectrum of primary lymphomas of the gastrointestinal tract.
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Lymphoma of the gall bladder is exceedingly rare with only anecdotal cases reported in
literature. We present the largest series of gall bladder lymphomas to date, based on a
retrospective study of 19 cases in our files. Fourteen patients had only loco regional
involvement (i.e. primary lymphoma), of which one had lymphoma involving the common
hepatic duct without gall bladder involvement. Five patients who presented with gall bladder
disease had systemic lymphoma on further work-up. In most instances the presenting
symptoms mimicked cholecystitis. Histologically, there was a diverse spectrum, including
many subtypes not previously documented in the gall bladder such as mantle cell lymphoma,
plasmablastic lymphoma, primary effusion lymphoma, and post-transplantation
lymphoproliferative disorder of T-cell type. In addition, we have also reviewed all the cases
reported in literature and present the clinicopathological features of primary gall bladder and
bile duct lymphomas.
Materials and methods
All cases with lymphomatous involvement of the gall bladder were retrieved from our
consultation files. This study was approved by the Institutional Review Board of the National
Cancer Institute (IRB protocol No. 10-C-N 074). Cases in which lymphoma was restricted to
the gall bladder with or without regional spread were identified, based on available and follow-
up information from referring pathologists and clinical charts. Additionally, we identified cases
in which gall bladder involvement was the initial clinical manifestation of disease, even when
subsequent evaluation revealed that the disease was not restricted to the gall bladder. However,
cases with a known prior diagnosis of lymphoma were excluded from study.
Clinical details, gross descriptions, and histological slides were reviewed. All cases were
classified according to the World Health Organization (WHO) classification (2008) for
hematolymphoid neoplasms(61). Immunostains performed on all cases included CD20, CD3,
Kappa and Lambda. Additional pertinent studies were performed in selected cases based on
the histologic differential diagnosis and included immunohistochemistry (CD79a, PAX5, CD2,
CD5, CD4, CD8, CD43, CYCLIN D1, CD10, BCL2, BCL6, Ki 67, IgD, IgG, IgA, IgM, CD30,
CD15, MUM1, CD138, P53, TdT, CD99, HHV8), in situ hybridization for EBV (EBER), and
molecular studies [IGH@ and TCR gamma gene rearrangements, fluorescence in situ
hybridization (FISH) for t(14;18)(q32;q21), t(11;14)(q13;q32) and t(8;14)(q24;q32)). IGH@
and TCR gamma gene rearrangements were identified by PCR analysis of DNA extracted from
formalin fixed paraffin embedded tissue. IGH@ PCR was performed using consensus primers
to framework region (II and/or III) and the joining region of the immunoglobulin heavy chain
gene(54), while TCR gamma gene PCR was performed using two separate primer sets with
primers Vg101, Vg11 and Jg12 (set 1) and primers Vg 101, Vg11 and Jp12 (set 2)(42).
A literature search was performed in PubMed using search words including gall bladder, bile
duct, cystic duct, and lymphoma, lymphoproliferative disorder or atypical lymphoid
hyperplasia. Publications were retrieved and reviewed to identify cases of primary gall bladder/
bile duct lymphoma. A few additional cases that had not been retrieved in the PubMed search
were identified by cross-references within the retrieved publications. All available clinical and
pathology data were tabulated.
Results
Clinical and pathological features – NIH cases
We identified 14 primary lymphomas, 13 involving the gall bladder and one involving the
extrahepatic bile ducts (Table 1). Patients were 5 to 84 (mean 57) years in age and included 10
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males and four females. Eleven of 12 cases (92%) with gall bladder lymphoma presented with
symptoms of cholecystitis, cholelithiasis or jaundice, while one case was detected incidentally;
no details were available in two cases. Three patients were immunocompromised (2 HIV
positive; 1 post-transplant), while two additional patients had colon cancer. Three of the 14
patients (23%) had B-symptoms. Four of 11 cases (36%) had gallstones. Regional
lymphadenopathy was intraoperatively identified in six cases. Histologically, regional lymph
nodes were involved by lymphoma in three of these six (50%) cases, while local contiguous
spread to surrounding soft tissue was present in two additional cases without nodal
involvement. There was a single case (case # 4) with a common hepatic duct mass, without
gall bladder involvement. This patient had undergone a gastric bypass surgery three years prior
to presenting with obstructive jaundice; there were no gall stones or regional lymphadenopathy.
None of the 14 cases had systemic disease.
Three cases of diffuse large B-cell lymphoma (DLBCL) were identified (3/14; 21.5%).
Following the Hans immunohistochemical algorithm(26), two of three were of germinal center
B-cell type, one of them with the t(14;18) involving the BCL2 and IGH@ genes. Two cases
of follicular lymphoma (FL), Grade 1–2, were observed, one of which presented as a localized
polypoid lesion of the mucosa (case #6). A third case of FL (case #4) presented in the common
bile duct and was Grade 3B. Two cases (2/14; 14.3%) of extranodal marginal zone lymphoma
(EMZL) were seen (Fig. 1), both of which showed extensive mucosal involvement. One case
of mantle cell lymphoma (MCL) (case # 8) had features of lymphomatous polyposis (Fig. 2).
It exhibited limited involvement of the mantle zones with neoplastic cells surrounding reactive
germinal centers. It was CD5-negative but SOX11+, and was positive for the t(11;14) by FISH.
A colonic resection performed at the same time for colonic adenocarcinoma showed no
involvement by lymphoma.Two HIV-associated lymphomas were identified: a solid variant
of primary effusion lymphoma (PEL) (case # 3) (Fig. 3) and plasmablastic lymphoma (PBL)
(case # 5) (Fig. 4). Two patients presented with B-lymphoblastic lymphoma (B-LBL) as the
sole manifestation of disease. The single patient with T-cell lymphoma was a 5-year-old boy
(case #1) who was status post-cardiac transplant on tacrolimus and presented with cholecystitis.
Histologically, there was transmural involvement by a clonal T-cell infiltrate, negative for EBV
by EBER-ISH.
Histologically, there was transmural involvement by lymphoma in ten cases (71.4%), while
four cases (28.6%) showed relative mucosal sparing with predominant smooth muscle and
adventitial involvement. The four cases with relative mucosal sparing included two patients
with DLBCL (case # 9 and 13) and one patient each with plasmablastic lymphoma (case # 5)
and B-LBL (case # 12).
Patients with DLBCL (cases # 9, 11, 13) and EMZL (cases # 10, 14) were older (72 to 84 years,
mean 75.8 years) than those with other subtypes (5 to 74 years, mean 46.6 years). Gallstones
were present in two of three cases (66%) with DLBCL, one of two cases (50%) with EMZL,
and only in one of eight (12.5%) cases with other lymphoma subtypes.
An additional five patients without a prior diagnosis of lymphoma presented with symptoms
of gall bladder disease and were diagnosed with lymphoma following cholecystectomy (Table
2). Unlike the first group of patients wherein the disease was restricted to the gall bladder and
regional lymph nodes, these five patients had widespread disease on further work-up. Thus,
although they had systemic involvement by lymphoma, they had come to clinical attention due
to gall bladder involvement. These five patients ranged in age from 38 to 85 years (mean 64.8
years) and included three females and two males. Four patients (80%) had B-symptoms. One
patient had Sjogren syndrome; none were immunocompromised. Only one of four patients
(25%) with available gross description had gall stones. Three patients (60%) had regional
lymphadenopathy at surgery, while all had systemic involvement on follow-up. Histologically,
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one patient had classical Hodgkin lymphoma, while the remaining four had B-cell lymphomas.
One case was a DLBCL with a double-hit translocation involving the BCL2 and MYC genes.
All five cases (100%) showed transmural involvement of the gall bladder wall.
Clinical and pathological features – Literature cases
The review of literature identified 52 cases of primary biliary lymphoma including 36 involving
the gallbladder and 16 involving only the extrahepatic bile ducts. Most patients had presented
with features suggestive of acute cholecystitis or obstructive jaundice; five were detected
incidentally on imaging or surgery for unrelated conditions. The 36 patients with primary
lymphoma of the gallbladder (Table 3) included 23 women and 13 men, aged 4 to 91 (mean
63) years. The most common lymphoma type was EMZL (12 cases)(1,6,7,14,35,43,45,49,53,
62,66,67), with an additional case from older literature (29) reported as “pseudolymphoma”.
Collectively, these 13 patients were predominantly women (11/13) with a mean age of 68 years
(range 31–91 years). Of the cases with clinical information, gall stones were present in 54.5%
(6/11) of cases and regional lymph nodes were involved in 20% (2/10) of cases. Of the eight
cases with reported outcomes, six (75%) were alive at follow-up (from 6 months to 8 years),
while two had died of unrelated diseases without recurrence of lymphoma. There were eight
cases of DLBCL(13,24,28,34,51,57,70,72), with an additional case of diffuse non-Hodgkin
lymphoma (NHL), not further specified(67). These nine patients averaged 64 (range 40–78)
years of age without gender predilection (4 women, 5men); 83.3% (5/6) cases had gallstones
and 28.6% (2/7) cases had lymph node involvement. Only one of nine (11%) patients had no
evidence of disease at 38 months(34), whereas others developed systemic disease, with three
patients dying within three years of diagnosis. The four cases of follicular lymphoma (22,31,
47,69) were also predominantly women with a mean age of 71 (range 63–78) years; gallstones
were present in two cases and one had regional lymph node involvement. All three patients
with available follow up information (from 9 months to 3 years) were alive without evidence
of disease. There were anecdotal reports of other lymphoma types including lymphoblastic
lymphoma, angiotropic or intravascular lymphoma, low grade B-cell lymphoma, poorly
differentiated lymphocytic lymphoma, classical Hodgkin lymphoma, and reports in older
literature diagnosed as lymphosarcoma and reticulum cell sarcoma.
In 16 cases identified in the literature, the lymphoma involved only the extrahepatic bile ducts
without gallbladder involvement (Table 4). These patients were 25 to 68 years old (mean 47
years) without gender predilection (9 women, 7 men) and had presented with obstructive
jaundice (15/16 cases, 93.8%). Only one patient (1/15, 6.7%) had regional nodal involvement
and gallstones (1/5, 20%). Of 12 patients with available follow-up information (from 6 months
to 4 years), four died of progressive disease (4/12, 33%), while eight were alive and in
remission. Preoperatively, all 16 patients were thought to have cholangiocarcinoma.
Histologically, there were seven cases (43.8%) of high grade B-cell lymphomas (three with
DLBCL, three with “diffuse small or medium cell lymphoma” and one with T-cell histiocyte
rich large B-cell lymphoma (TCHRBCL). Four patients (25%) had follicular lymphoma. There
was one case of EMZL, two EBV-PTLD in a post liver transplant setting, one T-cell NHL not
further specified and one “NHL” not further specified. Analysis of our cases combined with
those reported in literature identified certain clinicopathologic differences between lymphomas
of the gall bladder and extrahepatic bile ducts. Patients with bile duct lymphoma presented at
a younger age (mean 47 years) than those with gall bladder lymphoma (mean age 63 years).
All patients with bile duct lymphoma were symptomatic, whereas gallbladder lymphoma was
an incidental finding in a proportion of cases (8/47, 17%). There was no significant gender
predilection, although women were slightly more commonly affected in both groups (59% of
bile duct and 54% of gallbladder lymphomas). An association with gallstones was noted more
often in gallbladder lymphomas (21/42, 50%) than in bile duct lymphoma (1/6, 17%). Regional
lymph node involvement was also more frequent in gallbladder lymphomas (11/35, 31.4%,
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versus 1/16, 6.3%). Among histologic types, EMZL was distinctly uncommon in the bile ducts
(1/17, 5.9% of cases) as compared to the gall bladder (15/50, 30% of cases).
Discussion
Lymphomas of the gallbladder and extrahepatic bile ducts are exceedingly rare. Of a total of
1452 gall bladder specimens examined over a five-year-period, Darmas et al. found only one
case of lymphoma(18). Almost all documented cases of lymphomas at these sites have been
case reports and the present study represents the largest series of gall bladder lymphomas to
date. The majority of patients with gall bladder lymphoma present with symptoms of
cholecystitis. In our series, patients with DLBCL and EMZL were older and were more likely
to have gallstones than those with other lymphoma types. Even though the age distribution is
likely to be skewed by the presence of unusual lymphoma variants occurring in
immunocompromised hosts, all the patients with DLBCL and EMZL were older than 70 years
of age.
It is notable that the spectrum of gall bladder lymphomas mirrors the spectrum of lymphomas
observed in the gastrointestinal tract. In our study, the most common lymphoma types were
DLBCL, EMZL, FL, B-LBL with additional instances of extracavitary PEL and PBL, all
subtypes that may present with gastric or intestinal mucosal disease. When our cases are taken
in combination with those reported in literature, the most common lymphoma types in the gall
bladder/bile ducts are DLBCL and EMZL (16/66, 24% each) followed by FL (10/66, 15%)
and LBL (4/66, 6%). Comparative clinical features for these subtypes are shown in Table 5.
Primary lymphoma of the extrahepatic bile ducts is even more uncommon than gall bladder
lymphoma. We encountered only one case of bile duct lymphoma, adding to the 16 previously
reported cases. Bile duct lymphomas probably cause a clinically significant obstruction to bile
flow, possibly resulting in patients presenting earlier and with less frequent nodal involvement.
Similar to EMZL of other anatomic sites, those in the gall bladder show a female
preponderance. As in other sites, one can postulate that acquired mucosa associated lymphoid
tissue (MALT) secondary to infection or chronic inflammation may produce the substrate for
these lymphomas(30). In support of this hypothesis, Tomori et al have reported that although
the gall bladder normally has sparse lymphoid tissue, MALT may develop in 11% of
gallbladders in association with positive bile cultures and gallstones(65). On the other hand,
Angelopoulou et al hypothesize that in EMZL, the malignant transformation of the original
clone could have occurred outside the gall bladder with subsequent homing via an adhesion
molecule mechanism(3). Their hypothesis is supported by a recent report of sequential
development of a low grade MALT lymphoma affecting the stomach, the small intestine and
the gallbladder eight and three years apart, respectively(59). Tumor cells from all three sites
were shown to derive from a single clone by the demonstration of an identical immunoglobulin
heavy chain gene rearrangement using the polymerase chain reaction technique. Genetic
studies in one case showed a gall bladder EMZL to have the BIRC3/MALT1 translocation that
is most often associated with gastric EMZL(7).
In general, DLBCL is the most common type of extranodal lymphoma. In the gallbladder/bile
ducts, DLBCL occurs at a mean age of 60 years, without gender preference and is more likely
than the other subtypes to be associated with gallstones and regional lymph node involvement.
Gall bladder DLBCL has been postulated to evolve from follicular cholecystitis and low grade
MALT lymphomas(43). Although this is a possible explanation of lymphomagenesis at this
site, our cases with DLBCL were younger than those with EMZL, and had different
clinicopathologic features suggesting that these DLBCLs were more likely to be de novo
tumors rather than evolved from EMZL. In addition, we encountered a single case of FL, Grade
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3B, a tumor that is felt to be biologically closely related to DLBCL, and typically lacks both
BCL2 protein and the BCL2/IGH@ translocation(8).
Extranodal variants of DLBCL that we report for the first time in the gall bladder include PBL
and PEL. Both PBL and PEL typically affect HIV-positive patients, as was true in our cases.
The former most commonly involves the oral cavity(17), although involvement of other
mucosal sites, bone and soft tissue is often seen(20). PEL usually presents with body cavity
effusions without detectable mass lesions. However, the gastrointestinal tract is one of the more
common sites of extracavitary PEL, and progression to positive effusions is not always seen
(11,12,19). Our patient presented with an isolated gallbladder mass composed of large cells
that expressed MUM1, EMA, HHV8 (LANA), EBER and CD3 (cytoplasmic). Aberrant
expression of CD3 has been reported previously in instances of PEL, as well as other EBV-
positive large B-cell lymphomas(27,50). In addition to the cases of PEL and PBL, two cases
of angiotropic lymphoma were reported in literature (37,38) and occurred in older individuals.
Primary FL of the intestine differs clinically from primary nodal FL and was recognized in the
2008 WHO classification as a separate subtype(61). The duodenum is the most commonly
affected site(52,73). Similar to duodenal FL, we identified one case involving the gallbladder
that presented as an isolated polypoid lesion with localized mucosal disease without evidence
of systemic involvement. The single case of MCL also affected the gall bladder in a pattern
similar to lymphomatous polyposis of the intestine and represents the first documentation of
this lymphoma subtype at this site. Although the neoplastic cells expressed cyclin D1 and
SOX11, the tumor cells were negative for CD5, an uncommon feature in mantle cell lymphoma,
sometimes associated with indolent disease(23). Our case of MCL had disease limited to the
mantle zones, surrounding residual reactive germinal centers, and conforms to what has been
termed in situ MCL(4,55).
There were two cases of B-LBL. B-LBL is more likely than T-LBL to present with disease
outside of the hematolymphoid organs(39). In a large study of 25 cases of precursor B-LBL
without leukemic involvement, Lin et al. identified bone, soft tissue, and skin as the most
commonly involved sites, but two cases involved the gastrointestinal tract(39). In addition to
our two cases, there has been one previous report each of B-LBL(25) and T-LBL(44) involving
the gall bladder. None of the four cases had an associated gallstone or regional lymph node
disease.
Secondary involvement of the gall bladder in a systemic lymphoma is also rare; in a review of
1269 cases, the gallbladder was secondarily invaded in only 30 (2.4%) cases(56). In the present
study, five patients with systemic lymphoma initially presented with gallbladder disease. One
patient had classical Hodgkin lymphoma, while others had various forms of B-cell lymphoma.
Histologically, all five cases showed transmural involvement, similar to most of the cases with
primary gallbladder lymphoma, suggesting that histological pattern of gallbladder involvement
may not help differentiate primary and secondary lymphomas at this site.
In summary, we have detailed the clinicopathological spectrum of primary lymphomas of the
gallbladder and extrahepatic bile ducts based on an analysis of 14 cases from our files and a
review of 52 cases reported in literature. Gall bladder lymphomas present with non-specific
features of cholecystitis, whereas obstructive jaundice is more likely with bile duct disease. In
general, these lymphomas appear to recapitulate the spectrum of extranodal lymphomas
affecting the gastrointestinal tract, with a predominance of DLBCL, EMZL, and FL,
particularly of the primary intestinal or duodenal type. Although the inclusion of a number of
rare entities in our series, including in-situ MCL, PBL and solid PEL, relates to the nature of
our consultation practice, these subtypes also have been reported to occur in the intestine. The
very broad spectrum of disease types encountered underscores the need for detailed
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immunophenotypic analysis of gall bladder lymphocytic infiltrates for accurate diagnosis and
management.
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Fig. 1. Extranodal marginal zone lymphoma
A. The gall bladder mucosa is involved by a dense lymphoid infiltrate. B. Many cells exhibit
plasmacytoid differentiation whereas others have a rim of pale cytoplasm and a monocytoid
appearance.
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Fig. 2. Mantle cell lymphoma with features of lymphomatous polyposis
A. A polypoid infiltrate is present within the gall bladder mucosa. B. Cyclin D1 immunostain
highlights the neoplastic cells, which are largely confined to the mantle zones surrounding
negative reactive germinal centers.
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Fig. 3. Extracavitary variant of primary effusion lymphoma
A. The cells are large and pleomorphic with ample cytoplasm and prominent central
eosinophilic nucleoli. B. In-situ hybridization for EBV (EBER probe) and C. HHV-8
immunostain shows positivity in nuclei of neoplastic cells.
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Fig. 4. Plasmablastic lymphoma
A. There is a monomorphic infiltrate of cells with enlarged nuclei, prominent nucleoli and
moderate amount of eosinophilic cytoplasm. B. Neoplastic cells are strongly and diffusely
positive for MUM-1/IRF-4.
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